Analysis of exhaled breath condensate for monitoring airway inflammation

Trends in Pharmacological Sciences

Volumn 23, Issue 5, 2002, Pages 232-237

  Montuschi, Paolo ^a   Barnes, Peter J ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTAGLANDIN F2 ALPHA; BUDESONIDE; CORTICOSTEROID; HYDROGEN PEROXIDE; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NITRATE; NITRIC OXIDE; NITRITE; PROSTAGLANDIN; PROSTANOID; ROFECOXIB;

ADULT RESPIRATORY DISTRESS SYNDROME; ANALYTIC METHOD; ASTHMA; BREATH ANALYSIS; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COOLING; CYSTIC FIBROSIS; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DRUG MONITORING; EXPIRED AIR; HUMAN; LUNG FIBROSIS; METHODOLOGY; OXIDATIVE STRESS; PH; PNEUMONIA; PRIORITY JOURNAL; REPRODUCIBILITY; RESPIRATORY TRACT INFLAMMATION; REVIEW; SAMPLING; SMOKING CESSATION; STANDARDIZATION; VALIDATION PROCESS;

BREATH TESTS; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; INFLAMMATION MEDIATORS; ISOPROSTANES; LUNG DISEASES; NITRIC OXIDE; OXIDATIVE STRESS; PROSTAGLANDINS;

EID: 0036570289     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(02)02020-5     Document Type: Review

References (51)

1. Use of bronchoalveolar lavage in humans - past necessity and future imperative
2. Biopsy markers of airway inflammation and remodelling
3. Update on sputum methodology
4. Role of exhaled nitric oxide in asthma
5. Collection and analysis of exhaled breath condensate in humans
6. Exhaled markers of pulmonary disease
7. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients
8. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers
9. Increased nitrotyrosine in exhaled breath condensate of patients with asthma
10. The isoprostanes in biology and medicine
11. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS
12. Exhaled leukotrienes and prostaglandins in asthma
13. 2α, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro
14. Oxidative stress induced by acute ozone exposure is resistant to inhaled steroid treatment
15. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis
16. 2α in vitro and in vivo via the cyclooxygenases
17. 2 in patients with chronic obstructive pulmonary disease
18. 2α-III, an index of oxidant stress
19. Leukotrienes and inflammation
20. Increased levels of cysteinyl-leukotrienes in exhaled air condensate of aspirin-induced asthmatic patients
21. 4 in patients with asthma
22. Exhaled markers of inflammation in lung diseases
23. 2
24. 2: A new biomarker of airway inflammation in COPD
25. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate
26. 2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects
27. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma
28. Hydrogen peroxide in exhaled air is increased in stable asthmatic children
29. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients
30. Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients
31. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease
32. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: No significant effect of cigarette smoking
33. Validation of a new technique to assess exhaled hydrogen peroxide: Results from normals and COPD patients
34. Elevated levels of expired breath hydrogen peroxide in bronchiectasis
35. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS
36. Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis
37. Expired hydrogen peroxide in breath condensate of cystic fibrosis patients
38. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma
39. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: Effects of inhaled beclomethasone
40. Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment
41. Hydrogen peroxide in exhaled air of healthy children: Reference values
42. Reactive nitrogen species and tyrosine nitration in the respiratory tract
43. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure
44. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases
45. Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke
46. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide
47. Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis
48. Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis
49. Endogenous airway acidification. Implications for asthma pathophysiology
50. Detection of nonvolatile macromolecules in breath: A possible diagnostic tool?
51. Detection of IL-10 in the exhaled breath condensate, plasma and tissue during ischemia-reperfusion injury in experimental transplantation